*** Investor Presentation from Benchmark Holdings plc - video recording *** Trond Williksen, CEO, and Septima Maguire, CFO of Benchmark Holdings hosted an Investor Presentation following publication of their Q1 results for the period to 31 Dec 2023. Revenues were £40.5m for the quarter, 26% below a particularly strong Q1 FY23, but 11% above Q4 FY23, maintaining quarterly momentum. In Genetics, management discussed solid performance in the core salmon business and progress in growth vectors. In Advanced Nutrition, the company posted strong performance in Europe and in the Health division significant steps have been taken to transition to new business model for Ectosan® Vet and CleanTreat®. Watch the full presentation (dividend into chapters for ease of viewing, as below) for more details on period highlights and operational performance per division, including a Financial overview and an update on Outlook. https://lnkd.in/eJvYHqpD
Equity Development’s Post
More Relevant Posts
-
Many of today’s most critical life sciences products rely on advanced cold chain packaging to reach patients in optimal condition, ensuring the health and well-being of millions of people around the world. On top of consistent, flawless performance and product protection, today’s cold chain packaging must also support sustainability goals while keeping costs under control. This recent article discusses trends and opportunities in the cold chain packaging sector with Ranjeet Banerjee, CEO of Cold Chain Technologies.
-
Without advanced cold chain packaging, many of today’s most critical life sciences products would fail to reach patients in optimal condition, jeopardizing the health and well-being of millions of people around the world. Cold chain packaging must also support sustainability goals while keeping costs under control, requiring continual innovation. This recent article discusses trends and opportunities in the cold chain packaging sector with Ranjeet Banerjee, CEO of Cold Chain Technologies. https://lnkd.in/edVMXgZj
Innovative Cold Chain Solutions That Protect Patients
harriswilliams.com
-
Analyst presentation of Nordic LEVEL Group AB (publ) - Potental for 40-50% EBITDA CAGR Find the presentation here: https://lnkd.in/dd9bsMSc Equity analyst Markus Almerud follows up on Nordic LEVEL Group after Q1 and the announcement of new financial targets. He presents the investment case, discusses the ongoing transformation and put the new financial targets in context. $LEVEL
-
Explore our Investment Mapping for this week. Stay at the forefront with PRODENSA's Market Intelligence team. Find additional insights on www.prodensa.com. _ #InvestmentMapping #ProspectingStrategy #MarketIntelligence #BusinessGrowth #OpportunityIdentification #StrategicInsights #InvestmentProspects
-
Trailing return, a widely used metric for investment manager evaluation, is a poor predictor of performance, Mesirow Fiduciary Solutions found. Mesirow PrecisionAlpha®️, our answer to the shortcomings of traditional performance metrics, is a consistent predictor of performance across broad category sets for both one-year and three-year horizon periods. Read all about the findings, how we arrived at them, how our proprietary Mesirow PrecisionAlpha®️ process leverages them and what they mean for manager evaluation here: https://lnkd.in/ees7WqhA
-
Wishing all a prosperous and successful Financial Year 2024-25! May this year bring new opportunities, growth and financial stability. May we achieve all our financial goals and aspirations. Here's to a year of smart investments, wise financial decisions and fruitful collaborations. Happy Financial Year 2024-25! #financialyear #opportunities #growth #stability #collaborations #investments #healthbiotech #hbl
-
-
Exploring the wealth potential in the Pharma Sector for the coming years. 💼💊 Join the journey of financial growth through strategic investments. Learn, invest wisely, and secure your future. #PharmaWealth #FinancialGrowth #SmartInvesting #FinancialFreedomJourney #DebtFreeLife #InvestWisely #SmartMoneyMoves #GoalGetter #WealthBuilding #ConsultationCall
-
-
BCVG is celebrating 10 years of business! While our growth has been dynamic, we have been guided by a set of three deeply rooted principles that continue to serve us well. The analysis, insights, and guidance we provide drive critical decisions on strategy, asset allocation, and prioritization. It’s a big responsibility, and one we don’t take lightly. How can we help you reach your business goals? Schedule a meeting with us today: https://lnkd.in/em7xgH8i #BruderConsulting #BCVG #StrategicPlanning #PortfolioOptimization #medtech #biotech #managementconsulting #IntegratedInsights
-
-
New Investment Mapping for week 4 of december 2023. Stay at the forefront with PRODENSA's Market Intelligence team. Find additional insights on www.prodensa.com. _ #InvestmentMapping #ProspectingStrategy #MarketIntelligence #BusinessGrowth #OpportunityIdentification #StrategicInsights #InvestmentProspects
-
In this week’s podcast 🎙 - Neil Williams, Head of LeifBridge Investment Services, Ernst Knacke, Head of Investment Research, and Julian Wheeler, in-house US-Equity Specialist discuss the impact of technology and innovation on healthcare costs, the role of artificial intelligence in drug and molecule discovery, and the valuation disparities between biotech and big pharma. Topics include: 🔎 Exploring Healthcare Investment Opportunities 📈 The Value Proposition of Healthcare Investments 🔬Innovation and AI in Healthcare 🚩Addressing the Risks in Healthcare Sector Investments 🔦 Spotlight on Weight Loss Drugs and Market Dynamics 💼 Diving into Specific Investment Opportunities 📊 Healthcare Investment Strategies Listen in on the conversion below 👇🏼 #healthcare #biotech #podcast
Don’t miss out on our latest articles – subscribe to our monthly newsletters using the form below.
leifbridge.com
